Metro, Giulio: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

1

Osimertinib (AZD9291) and CNS Response in Two Radiotherapy-Naïve Patients withEGFR-Mutant and T790M-Positive Advanced Non-Small Cell Lung Cancer

Ricciuti, Biagio, Chiari, Rita, Chiarini, Pietro, Crinò, Lucio, Maiettini, Daniele, Ludovini, Vienna, Metro, Giulio

Journal:

Clinical Drug Investigation

Year:

2016

Language:

english

File:

PDF, 852 KB

english, 2016

2

Phase II study of weekly carboplatin in pretreated adult malignant gliomas

Villani, Veronica, Pace, Andrea, Vidiri, Antonello, Tanzilli, Antonio, Sperati, Francesca, Terrenato, Irene, Mariantonia, Carosi, Casini, Beatrice, Metro, Giulio, Maschio, Marta, Tatiana, Koudriavtsev

Journal:

Journal of Neuro-Oncology

Year:

2019

Language:

english

File:

PDF, 459 KB

english, 2019

3

ASTRIS: a global real-world study of osimertinib in >3000 patients with EGFR T790M positive non-small-cell lung cancer

Marinis, Filippo de, Wu, Yi-Long, de Castro, Gilberto, Chang, Gee-Chen, Chen, Yuh-Min, Cho, Byoung Chul, Freitas, Helano C, Jiang, Liyan, Kim, Sang-We, Martin, Claudio, Metro, Giulio, Provencio, Maria

Journal:

Future Oncology

Year:

2019

Language:

english

File:

PDF, 1.88 MB

english, 2019

4

Long-term survival with erlotinib in advanced lung adenocarcinoma harboring synchronous EGFR G719S and KRAS G12C mutations

Ricciuti, Biagio, Baglivo, Sara, Ludovini, Vienna, Sidoni, Angelo, Metro, Giulio, Brambilla, Marta, Siggillino, Annamaria, Reda, Maria Sole, Rebonato, Alberto, Maiettini, Daniele, Chiari, Rita

Journal:

Year:

2018

Language:

english

File:

PDF, 606 KB

english, 2018

5

Pathogenesis, Clinical Manifestations and Management of Immune Checkpoint Inhibitors Toxicity

Inno, Alessandro, Metro, Giulio, Bironzo, Paolo, Grimaldi, Antonio M., Grego, Elisabetta, Di Nunno, Vincenzo, Picasso, Virginia, Massari, Francesco, Gori, Stefania

Journal:

Year:

2017

Language:

english

File:

PDF, 383 KB

english, 2017

6

New targeted therapies for non-small-cell lung cancer

Metro, Giulio, Cappuzzo, Federico

Journal:

Year:

2009

Language:

english

File:

PDF, 627 KB

english, 2009

7

Erratum to: CT-Guided Percutaneous Trans-scapular Lung Biopsy in the Diagnosis of Peripheral Pulmonary Lesion Nodules of the Superior Lobes Using Large Needles

Rebonato, Alberto, Maiettini, Daniele, Andolfi, Marco, Fischer, Matthias J., Vannucci, Jacopo, Metro, Giulio, Basile, Antonio, Duranti, Michele, Rossi, Michele

Journal:

CardioVascular and Interventional Radiology

Year:

2017

Language:

english

File:

PDF, 301 KB

english, 2017

8

Cons: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?

Metro, Giulio, Di Maio, Massimo

Journal:

Translational Lung Cancer Research

Year:

2018

Language:

english

File:

PDF, 137 KB

english, 2018

9

Immune checkpoints inhibitors rechallenge in non-small-cell lung cancer: different scenarios with different solutions?

Metro, Giulio, Signorelli, Diego

Journal:

Lung Cancer Management

Year:

2019

File:

PDF, 519 KB

2019

10

Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating center

Alessandra Fabi, Alessandra Felici, Giulio Metro, Alessandra Mirri, Emilio Bria, Stefano Telera, Luca Moscetti, Michelangelo Russillo, Gaetano Lanzetta, Giovanni Mansueto, Andrea Pace, Marta Maschio,

Journal:

Journal of Experimental & Clinical Cancer Research

Year:

2011

Language:

english

File:

PDF, 298 KB

english, 2011

11

Do HER-2 positive metastatic breast cancer patients benefit from the use of trastuzumab beyond disease progression? A mono-institutional experience and systematic review of observational studies

Alessandra Fabi, Giulio Metro, Gianluigi Ferretti, Diana Giannarelli, Serena Di Cosimo, Paola Papaldo, Marcella Mottolese, Paolo Carlini, Alessandra Felici, Michelangelo Russillo, Francesco Cognetti

Journal:

Year:

2008

Language:

english

File:

PDF, 161 KB

english, 2008

12

Precision medicine against ALK-positive non-small cell lung cancer: beyond crizotinib

Ricciuti, Biagio, De Giglio, Andrea, Mecca, Carmen, Arcuri, Cataldo, Marini, Sabrina, Metro, Giulio, Baglivo, Sara, Sidoni, Angelo, Bellezza, Guido, Crinò, Lucio, Chiari, Rita

Journal:

Medical Oncology

Year:

2018

Language:

english

File:

PDF, 868 KB

english, 2018

13

Treatment of metastatic non-small cell lung cancer: 2018 guidelines of the Italian Association of Medical Oncology (AIOM)

Facchinetti, Francesco, Pilotto, Sara, Metro, Giulio, Baldini, Editta, Bertolaccini, Luca, Cappuzzo, Federico, Delmonte, Angelo, Gasparini, Stefano, Inno, Alessandro, Marchetti, Antonio, Passiglia, Fr

Journal:

Year:

2019

Language:

english

File:

PDF, 260 KB

english, 2019

14

Phase I–II trial of prolonged gemcitabine infusion plus paclitaxel as a biweekly schedule for advanced breast cancer patients pretreated with anthracyclines

Patrizia Vici, Alessandra Fabi, Giulio Metro, Domenico Sergi, Diana Giannarelli, Luigi Di Lauro, Gerold Bepler, Federica Tomao, Francesco Cognetti, Francesca Conti, Massimo Lopez

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2011

Language:

english

File:

PDF, 204 KB

english, 2011

15

Time to First Tumor Progression as Outcome Predictor of a Second Trasuzumab-Based Therapy beyond Progression in HER-2 Positive Metastatic Breast Cancer

Giulio Metro, Diana Giannarelli, Donatello Gemma, Gaetano Lanzetta, Mariangela Ciccarese, Paola Papaldo, Teresa Gamucci, Vito Lorusso, Marcella Mottolese, Emanuela Magnolfi, Francesco Cognetti, Alessa

Journal:

The Breast Journal

Year:

2010

Language:

english

File:

PDF, 165 KB

english, 2010

16

Future options for ALK-positive non-small cell lung cancer

Iacono, Daniela, Chiari, Rita, Metro, Giulio, Bennati, Chiara, Bellezza, Guido, Cenci, Matteo, Ricciuti, Biagio, Sidoni, Angelo, Baglivo, Sara, Minotti, Vincenzo, Crinò, Lucio

Journal:

Year:

2015

Language:

english

File:

PDF, 272 KB

english, 2015

17

Indoleamine 2,3-Dioxygenase 2 Immunohistochemical Expression in Resected Human Non-small Cell Lung Cancer: A Potential New Prognostic Tool

Mandarano, Martina, Bellezza, Guido, Belladonna, Maria Laura, Vannucci, Jacopo, Gili, Alessio, Ferri, Ivana, Lupi, Chiara, Ludovini, Vienna, Falabella, Giulia, Metro, Giulio, Mondanelli, Giada, Chiari

Journal:

Frontiers in Immunology

Year:

2020

File:

PDF, 764 KB

2020

18

Carboplatin plus pemetrexed for platinum-pretreated, advanced non-small cell lung cancer: a retrospective study with pharmacogenetic evaluation

Giulio Metro, R. Chiari, M. Mare, D. Giannarelli, F. R. Tofanetti, V. Minotti, M. Ferraldeschi, D. Giuffrida, L. Marcomigni, C. Bennati, M. J. Fischer, M. Meacci, R. Bellavita, L. Pistola, V. Ludovini

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2011

Language:

english

File:

PDF, 316 KB

english, 2011

19

Oral ondansetron is highly active as rescue antiemetic treatment for moderately emetogenic chemotherapy: results of a randomized phase II study

Alessandra Fabi, Mariangela Ciccarese, Giulio Metro, Antonella Savarese, Diana Giannarelli, Carmen M. Nuzzo, Michelangelo Russillo, Isabella Sperduti, Ilaria Carbone, Emilio Bria, Francesco Cognetti

Journal:

Supportive Care in Cancer

Year:

2008

Language:

english

File:

PDF, 125 KB

english, 2008

20

Emerging drugs for small cell lung cancer – an update

Metro, Giulio, Duranti, Simona, Fischer, Matthias Joachim, Cappuzzo, Federico, Crinò, Lucio

Journal:

Expert Opinion on Emerging Drugs

Year:

2012

Language:

english

File:

PDF, 212 KB

english, 2012

21

Emerging drugs for small-cell lung cancer

Metro, Giulio, Cappuzzo, Federico

Journal:

Expert Opinion on Emerging Drugs

Year:

2009

Language:

english

File:

PDF, 610 KB

english, 2009

22

HER-2-positive metastatic breast cancer: trastuzumab and beyond

Metro, Giulio, Mottolese, Marcella, Fabi, Alessandra

Journal:

Expert Opinion on Pharmacotherapy

Year:

2008

Language:

english

File:

PDF, 408 KB

english, 2008

23

Targeting NTRK fusion in non-small cell lung cancer: rationale and clinical evidence

Ricciuti, Biagio, Brambilla, Marta, Metro, Giulio, Baglivo, Sara, Matocci, Roberta, Pirro, Matteo, Chiari, Rita

Journal:

Medical Oncology

Year:

2017

Language:

english

File:

PDF, 650 KB

english, 2017

24

MA04.06 Signaling Networks in KRAS-Mutant Advanced NSCLC: A Complex Landscape Involving Immunoresponse, Inflammation and DNA Repair

Baglivo, Sara, Baldelli, Elisa, Crinò, Lucio, Ludovini, Vienna, Chiari, Rita, Metro, Giulio, Bennati, Chiara, Hodge, Alex, Siggillino, Annamaria, Tofanetti, Francesca Romana, Dong, Ting, Pistola, Lore

Journal:

Journal of Thoracic Oncology

Year:

2017

Language:

english

File:

PDF, 143 KB

english, 2017

25

P3.02c-068 Immunotherapy against Non-Small Cell Lung Cancer (NSCLC): Looking for Predictive Factors to Avoid an Untargeted Shooting

Paglialunga, Luca, Bellezza, Guido, Gili, Alessio, Ricciuti, Biagio, Minotti, Vincenzo, Chiari, Rita, Metro, Giulio, Ludovini, Vienna, Matocci, Roberta, Colabrese, Daniela, Baglivo, Sara, Crinò, Lucio

Journal:

Journal of Thoracic Oncology

Year:

2017

Language:

english

File:

PDF, 140 KB

english, 2017

26

Clinical experience with gefitinib: An update

Federico Cappuzzo, Giovanna Finocchiaro, Giulio Metro, Stefania Bartolini, Elisabetta Magrini, Alessandra Cancellieri, Rocco Trisolini, Luciano Castaldini, Giovanni Tallini, Lucio Crino

Journal:

Critical Reviews in Oncology/Hematology

Year:

2006

Language:

english

File:

PDF, 200 KB

english, 2006

27

Selumetinib: a promising pharmacologic approach for KRAS -mutant advanced non-small-cell lung cancer

Metro, Giulio, Chiari, Rita, Baldi, Alice, De Angelis, Verena, Minotti, Vincenzo, Crinò, Lucio

Journal:

Future Oncology

Year:

2013

Language:

english

File:

PDF, 1.16 MB

english, 2013

28

Osimertinib in patients with advanced epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: rationale, evidence and place in therapy

Ricciuti, Biagio, Baglivo, Sara, Paglialunga, Luca, De Giglio, Andrea, Bellezza, Guido, Chiari, Rita, Crinò, Lucio, Metro, Giulio

Journal:

Therapeutic Advances in Medical Oncology

Year:

2017

Language:

english

File:

PDF, 561 KB

english, 2017

29

Epidermal Growth Factor Receptor (EGFR) Targeted Therapies in Non- Small Cell Lung Cancer (NSCLC)

Metro, Giulio, Finocchiaro, Giovanna, Toschi, Luca, Bartolini, Stefania, Magrini, Elisabetta, Cancellieri, Alessandra, Trisolini, Rocco, Castaldini, Luciano, Tallini, Giovanni, Crino, Lucio, Cappuzzo,

Journal:

Reviews on Recent Clinical Trials

Year:

2006

Language:

english

File:

PDF, 138 KB

english, 2006

30

Successful Response to Osimertinib Rechallenge after Intervening Chemotherapy in an EGFR T790M-Positive Lung Cancer Patient

Metro, Giulio, Baglivo, Sara, Siggillino, Annamaria, Ludovini, Vienna, Chiari, Rita, Rebonato, Alberto, Bellezza, Guido

Journal:

Clinical Drug Investigation

Year:

2018

Language:

english

File:

PDF, 1011 KB

english, 2018

31

EGFR targeted therapy for lung cancer: are we almost there?

Journal:

Translational Lung Cancer Research

Year:

2018

File:

PDF, 171 KB

2018

32

Adjuvant treatment of non-small cell lung cancer: focus on targeted therapy

Tazza, Marco, Metro, Giulio

Journal:

Journal of Thoracic Disease

Year:

2017

Language:

english

File:

PDF, 187 KB

english, 2017

33

Cons: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?

Metro, Giulio, Di Maio, Massimo

Journal:

Translational Lung Cancer Research

Year:

2018

Language:

english

File:

PDF, 118 KB

english, 2018

34

Low-dose fotemustine for recurrent malignant glioma: a multicenter phase II study

Alessandra Fabi, Giulio Metro, Antonello Vidiri, Gaetano Lanzetta, Mariantonia Carosi, Stefano Telera, Marta Maschio, Michelangelo Russillo, Isabella Sperduti, Carmine M. Carapella, Francesco Cognetti

Journal:

Journal of Neuro-Oncology

Year:

2010

Language:

english

File:

PDF, 319 KB

english, 2010

35

Dramatic Response to Crizotinib in ROS1 Fluorescent In Situ Hybridization- and Immunohistochemistry-Positive Lung Adenocarcinoma: A Case Series

Chiari, Rita, Buttitta, Fiamma, Iacono, Daniela, Bennati, Chiara, Metro, Giulio, Di Lorito, Alessia, Iezzi, Manuela, Tiseo, Marcello, Mazzoni, Francesca, Cappuzzo, Federico, Marchetti, Antonio, Crinò,

Journal:

Clinical Lung Cancer

Year:

2014

Language:

english

File:

PDF, 1.30 MB

english, 2014

36

Large Cell Neuroendocrine Carcinoma Transformation and EGFR -T790M Mutation as Coexisting Mechanisms of Acquired Resistance to EGFR-TKIs in Lung Cancer

Baglivo, Sara, Ludovini, Vienna, Sidoni, Angelo, Metro, Giulio, Ricciuti, Biagio, Siggillino, Annamaria, Rebonato, Alberto, Messina, Salvatore, Crinò, Lucio, Chiari, Rita

Journal:

Mayo Clinic Proceedings

Year:

2017

Language:

english

File:

PDF, 3.03 MB

english, 2017

37

Correlations between the immune-related adverse events spectrum and efficacy of anti-PD1 immunotherapy in NSCLC patients

Cortellini, Alessio, Chiari, Rita, Ricciuti, Biagio, Metro, Giulio, Perrone, Fabiana, Tiseo, Marcello, Bersanelli, Melissa, Bordi, Paola, Santini, Daniele, Giusti, Raffaele, Grassadonia, Antonino, Mar

Journal:

Clinical Lung Cancer

Year:

2019

Language:

english

File:

PDF, 895 KB

english, 2019

38

Early stage resectable non-small cell lung cancer: is neoadjuvant immunotherapy the right way forward?

Chiari, Rita, Sidoni, Angelo, Metro, Giulio

Journal:

Journal of Thoracic Disease

Year:

2018

Language:

english

File:

PDF, 150 KB

english, 2018

39

Treatment of recurrent malignant gliomas with fotemustine monotherapy: impact of dose and correlation with MGMT promoter methylation

Alessandra Fabi, Giulio Metro, Michelangelo Russillo, Antonello Vidiri, Carmine Maria Carapella, Marta Maschio, Francesco Cognetti, Bruno Jandolo, Maria Alessandra Mirri, Isabella Sperduti, Stefano Te

Journal:

Year:

2009

Language:

english

File:

PDF, 241 KB

english, 2009

40

The safety of nivolumab for the treatment of advanced non-small cell lung cancer

Metro, Giulio, Ricciuti, Biagio, Brambilla, Marta, Baglivo, Sara, Soli, Irene, Minenza, Elisa, Leonardi, Giulia Costanza, D’Arpino, Alessandro, Colabrese, Daniela, Tazza, Marco, Zicari, Daniela, Minot

Journal:

Expert Opinion on Drug Safety

Year:

2016

Language:

english

File:

PDF, 1.04 MB

english, 2016

41

Identification of EML4-ALK Rearrangement and MET Exon 14 R988C Mutation in a Patient with High-Grade Neuroendocrine Lung Carcinoma Who Experienced a Lazarus Response to Crizotinib

Ricciuti, Biagio, Marcomigni, Luca, Metro, Giulio, Bellezza, Guido, Caselli, Emanuele, Baglivo, Sara, Chiari, Rita

Journal:

Journal of Thoracic Oncology

Year:

2018

Language:

english

File:

PDF, 826 KB

english, 2018

42

Cons: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?

Metro, Giulio, Di Maio, Massimo

Journal:

Translational Lung Cancer Research

Year:

2018

File:

PDF, 137 KB

2018

43

RET Rearrangement as a Predictor of Unresponsiveness to Immunotherapy in Non-Small Cell Lung Cancer: Report of Two Cases with Review of the Literature

Baglivo, Sara, Ludovini, Vienna, Moretti, Riccardo, Bellezza, Guido, Sidoni, Angelo, Roila, Fausto, Metro, Giulio

Journal:

Oncology and Therapy

Year:

2020

File:

PDF, 1.36 MB

2020

44

Brigatinib for anaplastic lymphoma kinase-tyrosine kinase inhibitor naÃ¯ve anaplastic lymphoma kinase-positive advanced non-small cell lung cancer: an effective but still broken option

Ricciuti, Biagio, Lamberti, Giuseppe, Roila, Fausto, Metro, Giulio

Journal:

Translational Lung Cancer Research

Year:

2019

File:

PDF, 165 KB

2019

45

Phase II study of fixed dose rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma multiforme

Giulio Metro, Alessandra Fabi, Maria A. Mirri, Antonello Vidiri, Andrea Pace, Mariantonia Carosi, Michelangelo Russillo, Marta Maschio, Diana Giannarelli, Domenica Pellegrini, Alfredo Pompili, Frances

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2010

Language:

english

File:

PDF, 312 KB

english, 2010

46

Targeting the KRAS variant for treatment of non-small cell lung cancer: potential therapeutic applications

Ricciuti, Biagio, Leonardi, Giulia Costanza, Metro, Giulio, Grignani, Francesco, Paglialunga, Luca, Bellezza, Guido, Baglivo, Sara, Mencaroni, Clelia, Baldi, Alice, Zicari, Daniela, Crinò, Lucio

Journal:

Expert Review of Respiratory Medicine

Year:

2016

Language:

english

File:

PDF, 683 KB

english, 2016

47

Anaplastic lymphoma kinase immunohistochemistry scores do not predict sensitivity to crizotinib in fluorescence in situ hybridization-positive non-small cell lung cancer patients

Metro, Giulio, Giannarelli, Diana, Sidoni, Angelo, Chiari, Rita, Bellezza, Guido

Journal:

The International Journal of Biological Markers

Year:

2018

Language:

english

File:

PDF, 162 KB

english, 2018

48

Malignant Giant Solitary Fibrous Tumor of the Pleura Metastatic to the Thyroid Gland

Ricciuti, Biagio, Metro, Giulio, Leonardi, Giulia Costanza, del Sordo, Rachele, Colella, Renato, Puma, Francesco, Ceccarelli, Silvia, Potenza, Rossella, Rebonato, Alberto, Maiettini, Daniele, Crinò, L

Journal:

Year:

2016

Language:

english

File:

PDF, 612 KB

english, 2016

49

Supportive care in neurooncology

Pace, Andrea, Metro, Giulio, Fabi, Alessandra

Journal:

Current Opinion in Oncology

Year:

2010

Language:

english

File:

PDF, 227 KB

english, 2010

50

Dramatic Response to Lorlatinib in a Heavily Pretreated Lung Adenocarcinoma Patient Harboring G1202R Mutation and a Synchronous Novel R1192P ALK Point Mutation

Baglivo, Sara, Ricciuti, Biagio, Ludovini, Vienna, Metro, Giulio, Siggillino, Annamaria, De Giglio, Andrea, Chiari, Rita

Journal:

Journal of Thoracic Oncology

Year:

2018

Language:

english

File:

PDF, 965 KB

english, 2018

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски